128 related articles for article (PubMed ID: 15367506)
1. Severe left ventricular hypertrophy in Anderson-Fabry disease.
Bhatia GS; Leahy JF; Connolly DL; Davis RC
Heart; 2004 Oct; 90(10):1136. PubMed ID: 15367506
[No Abstract] [Full Text] [Related]
2. Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease.
Gange CA; Link MS; Maron MS
Circulation; 2009 Sep; 120(13):e96-7. PubMed ID: 19786638
[No Abstract] [Full Text] [Related]
3. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
Takenaka T; Teraguchi H; Yoshida A; Taguchi S; Ninomiya K; Umekita Y; Yoshida H; Horinouchi M; Tabata K; Yonezawa S; Yoshimitsu M; Higuchi K; Nakao S; Anan R; Minagoe S; Tei C
J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
[TBL] [Abstract][Full Text] [Related]
4. [End-stage cardiac manifestations and autopsy findings in patients with cardiac fabry disease].
Teraguchi H; Takenaka T; Yoshida A; Taguchi S; Ninomiya K; Yoshida H; Horinouchi M; Yonezawa S; Nakao S; Minagoe S; Tei S
J Cardiol; 2004 Feb; 43(2):98-9. PubMed ID: 15046052
[TBL] [Abstract][Full Text] [Related]
5. The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease.
Weidemann F; Breunig F; Beer M; Sandstede J; Störk S; Voelker W; Ertl G; Knoll A; Wanner C; Strotmann JM
Eur Heart J; 2005 Jun; 26(12):1221-7. PubMed ID: 15728649
[TBL] [Abstract][Full Text] [Related]
6. Detection of Urinary Mulberry Bodies Leads to Diagnosis of Fabry Cardiomyopathy: A Simple Clue in the Urine Sediment.
Yano T; Takahashi R; Yamashita T; Nagano N; Ishikawa A; Sakurai A; Maruyama H; Miura T
Circ Heart Fail; 2017 Dec; 10(12):. PubMed ID: 29203563
[No Abstract] [Full Text] [Related]
7. Wide complex beats with ventricular hypertrophy: what is the mechanism?
Omar AR; Harris L; Cameron DA; Chauhan VS
J Cardiovasc Electrophysiol; 2006 Oct; 17(10):1150-2. PubMed ID: 16989653
[No Abstract] [Full Text] [Related]
8. Images in cardiovascular medicine. Transition from left ventricular hypertrophy to massive fibrosis in the cardiac variant of Fabry disease.
Hasegawa H; Takano H; Shindo S; Takeda S; Funabashi N; Nakagawa K; Toyozaki T; Kuwabara Y; Komuro I
Circulation; 2006 Apr; 113(16):e720-1. PubMed ID: 16636179
[No Abstract] [Full Text] [Related]
9. Effects of papillary muscles and trabeculae on left ventricular quantification: increased impact of methodological variability in patients with left ventricular hypertrophy.
Janik M; Cham MD; Ross MI; Wang Y; Codella N; Min JK; Prince MR; Manoushagian S; Okin PM; Devereux RB; Weinsaft JW
J Hypertens; 2008 Aug; 26(8):1677-85. PubMed ID: 18622248
[TBL] [Abstract][Full Text] [Related]
10. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of left ventricular hypertrophy by magnetic resonance imaging.
Shapiro EP
Am J Card Imaging; 1994 Oct; 8(4):310-5. PubMed ID: 7819725
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.
Weidemann F; Niemann M; Breunig F; Herrmann S; Beer M; Störk S; Voelker W; Ertl G; Wanner C; Strotmann J
Circulation; 2009 Feb; 119(4):524-9. PubMed ID: 19153271
[TBL] [Abstract][Full Text] [Related]
13. Altered myocardial motion pattern in Fabry patients assessed with CMR-tagging.
Rutz AK; Juli CF; Ryf S; Widmer U; Kozerke S; Eckhardt BP; Boesiger P
J Cardiovasc Magn Reson; 2007; 9(6):891-8. PubMed ID: 18066749
[TBL] [Abstract][Full Text] [Related]
14. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
[TBL] [Abstract][Full Text] [Related]
15. Importance of oblique fiber orientation for left ventricular wall deformation.
Shapiro EP; Rademakers FE
Technol Health Care; 1997 Apr; 5(1-2):21-8. PubMed ID: 9134616
[No Abstract] [Full Text] [Related]
16. Images in cardiovascular medicine. Diagnostic utility of cardiac magnetic resonance imaging in monozygotic twins with hypertrophic cardiomyopathy and identical pattern of left ventricular hypertrophy.
Maron BJ; Haas TS; Lesser JR
Circulation; 2007 Jun; 115(24):e627-8. PubMed ID: 17576874
[No Abstract] [Full Text] [Related]
17. [Fabry disease and ischemic cerebrovascular disease].
Orimo S
Nihon Rinsho; 1993 Dec; 51 Suppl():650-5. PubMed ID: 8121058
[No Abstract] [Full Text] [Related]
18. [Left ventricular hypertrophy and end-stage renal failure of unknown etiology: Fabry disease?].
Arévalo-Gómez A; Rivera-García S; López-Muñiz A; Barriales-Villa R
Rev Clin Esp; 2012 May; 212(5):265-6. PubMed ID: 22112280
[No Abstract] [Full Text] [Related]
19. The natural history of left ventricular systolic function in Anderson-Fabry disease.
Shah JS; Lee P; Hughes D; Thaman R; Sachdev B; Pellerin D; Mehta A; Elliott PM
Heart; 2005 Apr; 91(4):533-4. PubMed ID: 15772224
[No Abstract] [Full Text] [Related]
20. [Electrocardiogram in Fabry's disease].
Jastrzebski M; Petkow-Dimitrow P
Kardiol Pol; 2008 Jun; 66(6):688-92; discussion 692-3. PubMed ID: 18626840
[No Abstract] [Full Text] [Related]
[Next] [New Search]
